Retinitis pigmentosa: Defined from a molecular point of view

被引:208
|
作者
Van Soest, S
Westerveld, A
De Jong, PTVM
Bleeker-Wagemakers, EM
Bergen, AAB
机构
[1] Netherlands Ophthalm Res Inst, Dept Ophthalmoimmunol, NL-1100 AC Amsterdam, Netherlands
[2] Univ Amsterdam, Inst Human Genet, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Ophthalmol, Amsterdam, Netherlands
[4] Erasmus Univ, Inst Epidemiol & Biostat, Rotterdam, Netherlands
关键词
genetics; phosphodiesterase; photoreceptor retinal; pigment epithelium; retinitis pigmentosa; visual transduction; vitamin A;
D O I
10.1016/S0039-6257(98)00046-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Retinitis pigmentosa (RP) denotes a group of hereditary retinal dystrophies, characterized by the early onset of night blindness followed by a progressive loss of the visual field. The primary defect underlying RP affects the function of the rod photoreceptor cell, and, subsequently, mostly unknown molecular and cellular mechanisms trigger the apoptotic degeneration of these photoreceptor cells. Retinitis pigmentosa is very heterogeneous, both phenotypically and genetically. In this review Mle propose a tentative classification of RP based on the functional systems affected by the mutated proteins. This classification connects the variety of phenotypes to the mutations and segregation patterns observed in RT. Current progress in the identification of the molecular defects underlying RP reveals that at least three distinct functional mechanisms may be affected: 1) the daily renewal and shedding of the photoreceptor outer segments, 2) the visual transduction cascade, and 3) the retinol (vitamin A) metabolism. The first group includes the rhodopsin and peripherin/RDS genes, and mutations in these genes often result in a dominant phenotype. The second group is predominantly associated with a recessive phenotype that results, as we argue, from continuous inactivation of the transduction pathway. Disturbances in the retinal metabolism seem to be associated with equal rod and cone involvement and the presence of deposits in the retinal pigment epithelium. (C) 1999 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:321 / 334
页数:14
相关论文
共 50 条
  • [41] Gene therapy for retinitis pigmentosa
    Piri, Niloofar
    Grodsky, Jacob D.
    Kaplan, Henry J.
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2021, 11 (04) : 348 - 351
  • [42] Mechanisms of Apoptosis in Retinitis Pigmentosa
    Cottet, Sandra
    Schorderet, Daniel F.
    CURRENT MOLECULAR MEDICINE, 2009, 9 (03) : 375 - 383
  • [43] HLA typing and retinitis pigmentosa
    Castagna, I
    Fama, F
    Pettinato, G
    Palamara, F
    Trombetta, CJ
    OPHTHALMOLOGICA, 1996, 210 (03) : 152 - 154
  • [44] RETINITIS-PIGMENTOSA IN SPAIN
    AYUSO, C
    GARCIASANDOVAL, B
    NAJERA, C
    VALVERDE, D
    CARBALLO, M
    ANTINOLO, G
    CLINICAL GENETICS, 1995, 48 (03) : 120 - 122
  • [45] Retinal detachment in retinitis pigmentosa
    Chan, Weng Onn
    Brennan, Nicholas
    Webster, Andrew R.
    Michealides, Michel
    Muqit, Mahiul M. K.
    BMJ OPEN OPHTHALMOLOGY, 2020, 5 (01):
  • [46] Therapeutic targets for retinitis pigmentosa
    Sorbera, L. A.
    Dulsat, C.
    Graul, A., I
    DRUGS OF THE FUTURE, 2018, 43 (12) : 901 - 904
  • [47] An Update on Phosphodiesterase Mutations Underlying Genetic Etiology of Hearing Loss and Retinitis Pigmentosa
    Mittal, Rahul
    Bencie, Nicole
    Parrish, James M.
    Liu, George
    Mittal, Jeenu
    Yan, Denise
    Liu, Xue Zhong
    FRONTIERS IN GENETICS, 2018, 9
  • [48] Evaluation of the rhodopsin kinase gene in patients with retinitis pigmentosa
    Yamamoto, S
    Khani, SC
    Berson, EL
    Dryja, TP
    EXPERIMENTAL EYE RESEARCH, 1997, 65 (02) : 249 - 253
  • [49] Visual acuity changes in retinitis pigmentosa during pregnancy
    Vingolo, Enzo M.
    Salvatore, Serena
    Stagnitti, Franco
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 105 (03) : 269 - 269
  • [50] Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
    Wu, Kevin Y. Y.
    Kulbay, Merve
    Toameh, Dana
    Xu, An Qi
    Kalevar, Ananda
    Tran, Simon D. D.
    PHARMACEUTICS, 2023, 15 (02)